Alexandria Real Estate Equities
ARE
$115.69
Share price
-0.70%
Change (1 day)
-6.85%
Change (1 year)
Categories
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.
Alexandria Real Estate Equities (ARE) Fails to deliver data
Key failure to deliver metrics for Alexandria Real Estate Equities :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.36 M
- Last 3 months FTD volume: $29.34 M
- Last year FTD volume: $55.98 M
Failures to deliver for Alexandria Real Estate Equities (ARE) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Alexandria Real Estate Equities (ARE) - since 2013
Volume in USD (price x number of shares), data since 2013Alexandria Real Estate Equities (ARE) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $21.83 M | -46.98% |
| 2023 | $41.18 M | -64.08% |
| 2022 | $0.11 B | 22.18% |
| 2021 | $93.85 M | -16.64% |
| 2020 | $0.11 B | 38.94% |
| 2019 | $81.03 M | -10.89% |
| 2018 | $90.94 M | -43.57% |
| 2017 | $0.16 B | 192.01% |
| 2016 | $55.19 M | 125.93% |
| 2015 | $24.42 M | 11.4% |
| 2014 | $21.92 M | 875.57% |
| 2013 | $2.24 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $31.87 M | $0.32 B | 🇺🇸 USA |
 Eli Lilly LLY | $50.92 M | $0.12 B | 🇺🇸 USA |
 Amgen AMGN | $65.7 M | $0.18 B | 🇺🇸 USA |
 Gilead Sciences GILD | $49.76 M | $0.27 B | 🇺🇸 USA |
 Illumina ILMN | $1.26 M | $0.10 B | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $0.19 B | $0.29 B | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | $15.22 M | $43.68 M | 🇺🇸 USA |